Komori
Share Issuance and Disposal4599StemRIM Inc.Pharmaceuticals

Notice Regarding Finalization of the Issuance Terms for Stock Options (Share Acquisition Rights) Granted to the Company's Executive Officers and Employees

The previously undecided issuance terms for the 19th Share Acquisition Rights (A), approved the previous day, have been finalized. Stock options covering a total of 4,989 rights (498,900 underlying shares) will be granted to 47 executive officers and employees.

Worth reading
37Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
498900
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of Stock Options (Share Acquisition Rights) for the Company's Executive Officers and Employees (株式会社ステムリム 19th Share Acquisition Rights (A))

Who receives how much

498,900 shares of the Company's common stock (100 shares per share acquisition right)

47 of the Company's executive officers and employees498,900 shares

The lower thin line represents the existing number of shares to which these shares will be added.

Terms of the stock acquisition rights
Exercise price
¥24,500 per share acquisition right (¥245 per share); adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issuance: 4,989 share acquisition rights; unexercised balance: Not disclosed
Categories and Number of Persons Covered
47 of the Company's executive officers and employees; 498,900 shares allocated
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of Stock Options (Share Acquisition Rights) for the Company's Executive Officers and Employees (株式会社ステムリム 19th Share Acquisition Rights (A))
Number of shares to be issued or disposed of498,900 shares of the Company's common stock (100 shares per share acquisition right)
Intended allotteeName 47 of the Company's executive officers and employees / Number of Shares 498,900 shares
Exercise price¥24,500 per share acquisition right (¥245 per share); adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition RightsTotal issuance: 4,989 share acquisition rights; unexercised balance: Not disclosed
Categories and Number of Persons Covered47 of the Company's executive officers and employees; 498,900 shares allocated
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the previously undecided matters concerning the stock options approved at the Board of Directors meeting held on 9 September 2026 have been finalized.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Finalization of the Issuance Terms for Stock Options (Share Acquisition Rights) Granted to the Company's Executive Officers and Employees | StemRIM Inc. (4599) timely disclosure | Komori